Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Am J Dent ; 21(3): 171-4, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18686769

RESUMEN

PURPOSE: To evaluate the influence of a triclosan-polydimethylsiloxane-containing gel when used as an adjunct to scaling and root planing on the treatment of chronic periodontal disease. METHODS: A 3-month, double-blind, randomized parallel design clinical trial was performed in 20 subjects with chronic periodontitis. The subjects, presenting at least three anterior sites with probing depth (PD) +/- 5 mm and bleeding on probing (BoP), were randomly assigned to two experimental groups: Group SRP-T: scaling/root planing plus test gel application (triclosan 1% + polydimethylsiloxane 13%) or Group SRP: scaling/root planing plus control gel application (polydimethylsiloxane 13%). Immediately following mechanical therapy, each assigned gel was applied to the selected sites and once a week during the following 3 weeks. Re-examinations were carried out on days 45 and 90 after the last irrigation. RESULTS: Significant reductions in PD and clinical attachment level (CAL) were observed for both groups in both periods (P < 0.05). However, SRP-T showed lower means of PD than SRP at Day 45 (3.60 +/- 0.87 versus 4.77 +/- 1.38, respectively, P = 0.035) and CAL at both 45 days (4.63 +/- 1.17 versus 6.07 +/- 1.43, P = 0.023) and 90 days (4.45 +/- 1.19 versus 5.91 +/- 1.37, P = 0.021). No differences were found for bleeding on probing, plaque index and gingival recession (P > 0.05) between groups.


Asunto(s)
Antiinfecciosos Locales/uso terapéutico , Raspado Dental , Dimetilpolisiloxanos/uso terapéutico , Periodontitis/terapia , Aplanamiento de la Raíz , Triclosán/uso terapéutico , Administración Tópica , Adulto , Antiinfecciosos Locales/administración & dosificación , Terapia Combinada , Índice de Placa Dental , Dimetilpolisiloxanos/administración & dosificación , Método Doble Ciego , Femenino , Estudios de Seguimiento , Hemorragia Gingival/tratamiento farmacológico , Hemorragia Gingival/terapia , Recesión Gingival/tratamiento farmacológico , Recesión Gingival/terapia , Humanos , Masculino , Pérdida de la Inserción Periodontal/tratamiento farmacológico , Pérdida de la Inserción Periodontal/terapia , Bolsa Periodontal/tratamiento farmacológico , Bolsa Periodontal/terapia , Periodontitis/tratamiento farmacológico , Triclosán/administración & dosificación
2.
Implant Dent ; 17(4): 461-70, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19077584

RESUMEN

PURPOSE: Although the harmful effect of tobacco smoking on titanium implants has been documented, no studies have investigated the effects of cannabis sativa (marijuana) smoking. Thus, this study investigated whether marijuana smoke influences bone healing around titanium implants. MATERIALS: Thirty Wistar rats were used. After anesthesia, the tibiae surface was exposed and 1 screw-shaped titanium implant was placed bilaterally. The animals were randomly assigned to one of the following groups: control (n = 15) and marijuana smoke inhalation (MSI) 8 min/d (n = 15). Urine samples were obtained to detect the presence of tetra-hidro-cannabinoid. After 60 days, the animals were killed. The degree of bone-to-implant contact and the bone area within the limits of the threads of the implant were measured in the cortical (zone A) and cancellous bone (zone B). RESULTS: Tetra-hidro-cannabinoid in urine was positive only for the rats of MSI group. Intergroup analysis did not indicate differences in zone A-cortical bone (P > 0.01), however, a negative effect of marijuana smoke (MSI group) was observed in zone B-cancellous bone for bone-to-implant contact and bone area (Student's t test, P < 0.01) values. CONCLUSIONS: Considering the limitations of the present study, the deleterious impact of cannabis sativa smoke on bone healing may represent a new concern for implant success/failure.


Asunto(s)
Implantes Dentales , Dronabinol/efectos adversos , Fumar Marihuana/efectos adversos , Oseointegración/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Animales , Implantes Experimentales , Masculino , Distribución Aleatoria , Ratas , Ratas Wistar , Tibia
3.
J Periodontol ; 78(4): 730-5, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17397322

RESUMEN

BACKGROUND: It is well recognized that cigarette consumption is a strong risk factor for periodontitis. Tobacco companies have developed a cigarette with low levels of toxic compounds; however, its effect on periodontium has not been investigated. The aim of this study was to verify the impact of smoke produced by low- and high-yield cigarettes on bone loss resulting from ligature-induced periodontitis. METHODS: A total of 36 male Wistar rats were used in the study. A ligature was placed around one of the mandibular first molars (ligated teeth) of each animal, and they were assigned randomly to one of three groups: group 1: control (N = 10), group 2: 30 days' inhalation of smoke produced by high-yield cigarettes (N = 13), and group 3: 30 days' inhalation of smoke produced by low-yield cigarettes (N = 13). The animals were sacrificed 30 days after ligature placement, and the specimens were processed for decalcified sections. RESULTS: Intergroup analysis of unligated teeth (without periodontal disease) did not show a significant difference regarding periodontal ligament area (2.40 +/- 0.5 mm(2), 2.72 +/- 0.7 mm(2), and 2.61 +/- 0.4 mm(2) for groups 1, 2, and 3, respectively; P >0.05). Conversely, significant differences were noted in ligated teeth (with periodontitis); bone loss was directly proportional to the level of toxic compounds in the cigarettes (5.74 +/- 0.5 mm(2), 7.40 +/- 0.50 mm(2), and 6.51 +/- 0.50 mm(2) for groups 1, 2, and 3, respectively; P <0.05). CONCLUSION: Low- and high-yield cigarettes potentiated bone loss during experimental periodontitis in a directly proportional fashion.


Asunto(s)
Pérdida de Hueso Alveolar/inducido químicamente , Inmunosupresores/efectos adversos , Nicotiana/toxicidad , Periodontitis/etiología , Humo/efectos adversos , Breas/efectos adversos , Animales , Masculino , Enfermedades Mandibulares/inducido químicamente , Ratas , Ratas Wistar , Nicotiana/química
4.
J Periodontol ; 75(3): 348-52, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15088871

RESUMEN

BACKGROUND: The aim of the present study was to verify nicotine effects on alveolar bone changes induced by occlusal trauma during a periodontitis experimental model in rats. METHODS: Thirty adult male rats were used. The animals were randomly assigned to one of three groups receiving daily intraperitoneal injections: A, nicotine solution (0.44 mg/ml) and occlusal overload; B, saline solution and occlusal overload; or C, saline solution. Rats from groups A and B underwent bilateral amputation of the second and third molar cusps to simulate an occlusal overload. The first molars were then randomly assigned to receive a cotton ligature in the sulcular area, while the contralateral tooth was left unligated. The animals were sacrificed 30 days later. The resected mandibles were processed, and histomorphometric measurements were performed in the alveolar bone adjacent to the furcation area of the first molars. RESULTS: Nicotine enhanced the bone loss induced by occlusal trauma (P<0.001) on the ligated teeth of group A (12.27 +/- 4.4 mm2), when compared to groups B (8.43 +/- 3.51 mm2) and C (4.43 +/- 2.17 mm2). Alveolar bone loss (P<0.01) was also observed in the contralateral teeth of groups A (nicotine + trauma) and B (saline + trauma), when compared to group C (saline only). CONCLUSION: Within the limits of the study, it is concluded that nicotine may influence the alveolar bone changes induced by occlusal trauma by enhancing bone loss.


Asunto(s)
Proceso Alveolar/efectos de los fármacos , Oclusión Dental Traumática/complicaciones , Nicotina/efectos adversos , Agonistas Nicotínicos/efectos adversos , Pérdida de Hueso Alveolar/etiología , Pérdida de Hueso Alveolar/fisiopatología , Proceso Alveolar/patología , Animales , Modelos Animales de Enfermedad , Masculino , Análisis por Apareamiento , Periodontitis/complicaciones , Distribución Aleatoria , Ratas , Ratas Wistar , Cloruro de Sodio , Estadísticas no Paramétricas
5.
Rev. cir. traumatol. buco-maxilo-fac ; 5(4): 37-42, out.-dez. 2005. ilus
Artículo en Portugués | LILACS, BBO - odontología (Brasil) | ID: biblio-872949

RESUMEN

A anquilose da articulação têmporo-mandibular é uma doença rara, resultante da fusão do côndilo mandibular com a base do crânio, envolvendo alterações anátomo-clínicas. Trauma e infecção são os principais fatores etiológicos dessa patologia, que tem como método de tratamento a terapia cirúrgica associada à fisioterapia prolongada. O caso relatado é de um paciente de 20 anos de idade, assintomático, que apresentava abertura bucal de 3 mm, e que foi diagnosticado como anquilose da articulação têmporo-mandibular do tipo I de SAWHNEY após agressão por arma de fogo. O tratamento proposto foi a artroplastia interposicional seguida de coronoidectomia ipsilateral e reabilitação fisioterápica.


Asunto(s)
Adulto , Anquilosis , Artroplastia de Reemplazo , Articulación Temporomandibular/patología
6.
Periodontia ; 14(1): 46-50, mar. 2004.
Artículo en Portugués | LILACS, BBO - odontología (Brasil) | ID: lil-500836

RESUMEN

Estudos têm estabelecido uma relação entre osteopenia, osteoporose e doença periodontal, em que a perda de massa óssea sistêmica foi relacionada com a perda dental pela reabsorção do osso alveolar de sustentação. No intuito de inibir a perda óssea provocada pela osteoporose, a literatura médica tem sugerido o uso de drogas que atuam na fisiopatologia óssea como os estrógenos. os bisfosfonatos, os flavonóides sintéticos e mais recentemente os fitoestrógenos naturais. Os fitoestrógenos (flavonóides naturais) são substâncias encontradas naturalmente no gérmen de soja e que têm sido indicados na prevenção da osteoporose. devido à sua ação direta no metabolismo ósseo. Além disso, tem sido destacado seu efeito anti-inflamatório moderado. Logo. este trabalho visa apresentar e questionar os possíveis benefícios deste novo medicamento na perda óssea periodontal.


Asunto(s)
Enfermedades Óseas Metabólicas , Enfermedades Periodontales , Fitoestrógenos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA